Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|10|2|76-83

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.10, Iss.2, 2010-04, pp. : 76-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Current and Emerging Drug Targets for Human Immunodeficiency Virus)

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-04 ,pp. : 1072-1073

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotransmitter Effects in Human Immunodeficiency Virus (HIV) and Simian Immuno-Deficiency Virus (SIV) Infection

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 2, 2009-06 ,pp. : 153-163

Bentham Science Publishers

Access to resources Recommend Favorite

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

By Argyris E.   Paterson Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 239-243

Informa Healthcare

Access to resources Recommend Favorite

Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV)

By  

Pharmaceutical Nanotechnology, Vol. 6, Iss. 1, 2018-04 ,pp. : 17-27

Bentham Science Publishers

Access to resources Recommend Favorite

Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1433-1439

Bentham Science Publishers

Access to resources Recommend Favorite